These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
360 related articles for article (PubMed ID: 24550577)
1. Hedgehog signaling pathway: a novel target for cancer therapy: vismodegib, a promising therapeutic option in treatment of basal cell carcinomas. Abidi A Indian J Pharmacol; 2014; 46(1):3-12. PubMed ID: 24550577 [TBL] [Abstract][Full Text] [Related]
2. Vismodegib: an inhibitor of the Hedgehog signaling pathway in the treatment of basal cell carcinoma. Proctor AE; Thompson LA; O'Bryant CL Ann Pharmacother; 2014 Jan; 48(1):99-106. PubMed ID: 24259609 [TBL] [Abstract][Full Text] [Related]
3. A comprehensive review of the role of the hedgehog pathway and vismodegib in the management of basal cell carcinoma. Erdem GU; Sendur MA; Ozdemir NY; Yazıcı O; Zengin N Curr Med Res Opin; 2015 Apr; 31(4):743-56. PubMed ID: 25690490 [TBL] [Abstract][Full Text] [Related]
4. Vismodegib and the hedgehog pathway: a new treatment for basal cell carcinoma. Cirrone F; Harris CS Clin Ther; 2012 Oct; 34(10):2039-50. PubMed ID: 23036338 [TBL] [Abstract][Full Text] [Related]
5. Vismodegib: a promising drug in the treatment of basal cell carcinomas. Dirix L; Rutten A Future Oncol; 2012 Aug; 8(8):915-28. PubMed ID: 22894666 [TBL] [Abstract][Full Text] [Related]
6. Targeting the hedgehog pathway to treat basal cell carcinoma. Geeraert P; Williams JS; Brownell I J Drugs Dermatol; 2013 May; 12(5):519-23. PubMed ID: 23652945 [TBL] [Abstract][Full Text] [Related]
7. Hedgehog Pathway Inhibition. Sekulic A; Von Hoff D Cell; 2016 Feb; 164(5):831. PubMed ID: 26919418 [TBL] [Abstract][Full Text] [Related]
19. A Vismodegib Experience in Elderly Patients with Basal Cell Carcinoma: Case Reports and Review of the Literature. Passarelli A; Galdo G; Aieta M; Fabrizio T; Villonio A; Conca R Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202689 [TBL] [Abstract][Full Text] [Related]
20. Radiation Sensitization of Basal Cell and Head and Neck Squamous Cell Carcinoma by the Hedgehog Pathway Inhibitor Vismodegib. Hehlgans S; Booms P; Güllülü Ö; Sader R; Rödel C; Balermpas P; Rödel F; Ghanaati S Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]